logo
Focus on what really matters: the patient.
Mark the 28th of November 2024 on your calendars.
The future begins now.
Be part of it.

MTT-Line Progressive Resistance Training

A publication from Flansbjer et al. (2012) examined the long-term benefits of medical training therapy (MTT) in chronic stroke patients. The intervention group participated in a supervised resistance training of the lower extremities twice weekly for 10 weeks, whereas the control group continued their usual daily activities. The study showed that training on pneumatic resistance devices effectively improves and maintains muscle strength in stroke survivors. Even 4 years after the intervention, there were still significant differences in both isotonic and isokinetic strength between the training and the control group. The study was the first to show that the improvements in muscle strength not only occurred immediately after the intervention but were maintained on a long-term perspective.

Medical Training Therapy (MTT) supports and complements neurorehabilitation with robotic and sensory devices. The Tyromotion MTT-LINE provides a set of Medical Training Therapy devices specifically for the neurorehabilitation sector.

 

Flansbjer et al. 2012 Long-term benefits of progressive resistance training in chronic stroke: a 4-year follow-up.

Newsletter Anmeldung

Tyromotion GmbH - Headquarters

Bahnhofgürtel 59
8020 Graz, AUSTRIA
Phone: +43 316 908 909
Fax: +43 316 231123 9144
Mail: office@tyromotion.com

Tyromotion Inc - USA

1341 Capital Circle, SE
Suite J
Marietta, GA 30067, USA
Phone: + 1 678 903 8915
Fax: + 1 888 845 4494
Mail: usa@tyromotion.com

Tyromotion Contact Deutschland

Phone: +49 9721 533 53 90
Mail: deutschland@tyromotion.com

Tyromotion Contact Switzerland

Mail: schweiz@tyromotion.com

Website by Rubikon Werbeagentur GmbH

Appointment request

    We are happy to contact you to schedule a demo at your facility.


    Your contact information will be stored for the purpose of contacting you within the scope of this request. By submitting this form you agree to this use. Further information can be found in our privacy policy.